Picture of China East Education Holdings logo

667 — China East Education Holdings News Story

0.000.00%
hk flag iconLast trade - 00:00
IndustrialsSpeculativeMid CapContrarian

China East Education H1 profit rises on increased student enrollment

China East Education H1 profit rises on increased student enrollment


Overview

  • China vocational education provider's interim revenue grew 10.6% yr/yr for six months ended June

  • Net profit for six months rose 13% yr/yr; gross profit increased 12.4% yr/yr

  • Company expanded to 233 schools and centers, new student enrollments up 6.8%


Outlook

  • Group intends to expand its school network to all provincial capital cities in China and other cities overseas

  • China East Education plans to expand course offerings and explores pet, artificial intelligence and healthcare markets


Result Drivers

  • STUDENT ENROLLMENT - Revenue growth and gross-margin expansion reflected 6.8% more new enrolments and a strategy to attract higher-value students through an optimised course structure

  • HIGHER GROSS PROFIT - Gross profit increased 12.4% yr/yr primarily due to high-value new students enrollment and the scaling efficiency

  • SCHOOL NETWORK EXPANSION - Co expanded to 233 schools and centers, up from 230 at end-2025


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

H1 Revenue

RMB 2.42 bln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the professional & business education peer group is "buy"

  • Wall Street's median 12-month price target for China East Education Holdings Ltd is HK$8.68, about 99.8% above its August 19 closing price of HK$4.35

  • The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 10 three months ago


Reuters Recommended Reads

  • Aug 18 - China's 361 Degrees International interim revenue rises 8%

  • Aug 19 - Sino Biopharmaceutical H1 revenue up 10.6% on innovative drug sales

  • Aug 17 - China Lilang H1 revenue rises on operational efficiency improvement, longer peak season sales


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on China East Education Holdings

See all news